SCHEMBL6092015

SCHEMBL6092015

Cc1ccsc1[C@H]1Sc2ccccc2NC(=O)[C@H]1NC(=O)[C@@H](N)CC(=O)Cc1cccc(F)c1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.33
MAPK8 P45983 1/20 0.33
HSD17B10 Q99714 3/20 0.32
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 3/20 0.31
KMT2A Q03164 3/20 0.31
ALDH1A1 P00352 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C9 P11712 1/20 0.31
MAPK1 P28482 1/20 0.31
CYP2C19 P33261 1/20 0.31
HIF1A Q16665 1/20 0.31
MAPT P10636 1/20 0.31
NPC1 O15118 1/20 0.31
TSHR P16473 1/20 0.31
TP53 P04637 1/20 0.31
PKM P14618 1/20 0.31
VNN1 O95497 1/20 0.31
PSEN1 P49768 1/20 0.30
PSEN2 P49810 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5229108 0.80 HSD17B10 (0.40) HTTHSD17B10KDM4EMEN1KMT2A
SCHEMBL3343550 0.79 PSEN1 (0.43) MEN1KMT2APKMPSEN1PSEN2
SCHEMBL3340772 0.72 PSEN1 (0.43) MEN1KMT2APKMPSEN1PSEN2
SCHEMBL3343552 0.72 KDM4E (0.37) HTTHSD17B10KDM4EMEN1KMT2A
SCHEMBL5229104 0.71 HSD17B10 (0.39) HTTHSD17B10KDM4EMEN1KMT2A
SCHEMBL4125092 0.69 HSD17B10 (0.51) HTTHSD17B10KDM4EMEN1KMT2A
SCHEMBL3343210 0.67 PSEN1 (0.44) MEN1KMT2AMAPTPKMPSEN1
SCHEMBL3345093 0.66 PSEN1 (0.47) HSD17B10KDM4EMEN1KMT2APKM
SCHEMBL5225903 0.66 HSD17B10 (0.55) HTTHSD17B10KDM4EMEN1KMT2A
SCHEMBL3346163 0.66 HSD17B10 (0.55) HTTHSD17B10KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060089346-A1 Novel lactams and uses thereof ASTRAZENECA AB (SE) 2006-04-27 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060089346-A1 Novel lactams and uses thereof BACE1, BACE2, APH1B HTT 1749/4885MAPK8 4142/4885HSD17B10 512/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.